» Articles » PMID: 38786270

Particles in Exhaled Air (PExA): Clinical Uses and Future Implications

Overview
Specialty Radiology
Date 2024 May 24
PMID 38786270
Authors
Affiliations
Soon will be listed here.
Abstract

Access to distal airway samples to assess respiratory diseases is not straightforward and requires invasive procedures such as bronchoscopy and bronchoalveolar lavage. The particles in exhaled air (PExA) device provides a non-invasive means of assessing small airways; it captures distal airway particles (PEx) sized around 0.5-7 μm and contains particles of respiratory tract lining fluid (RTLF) that originate during airway closure and opening. The PExA device can count particles and measure particle mass according to their size. The PEx particles can be analysed for metabolites on various analytical platforms to quantitatively measure targeted and untargeted lung specific markers of inflammation. As such, the measurement of distal airway components may help to evaluate acute and chronic inflammatory conditions such as asthma, chronic obstructive pulmonary disease, acute respiratory distress syndrome, and more recently, acute viral infections such as COVID-19. PExA may provide an alternative to traditional methods of airway sampling, such as induced sputum, tracheal aspirate, or bronchoalveolar lavage. The measurement of specific biomarkers of airway inflammation obtained directly from the RTLF by PExA enables a more accurate and comprehensive understanding of pathophysiological changes at the molecular level in patients with acute and chronic lung diseases.

Citing Articles

Chemical Analysis of Deep-Lung Fluid Derived from Exhaled Breath Particles.

Kakeshpour T, Louis J, Walter P, Bax A Anal Chem. 2025; 97(7):4128-4136.

PMID: 39949307 PMC: 11859745. DOI: 10.1021/acs.analchem.4c06422.

References
1.
Larsson P, Larstad M, Bake B, Hammar O, Bredberg A, Almstrand A . Exhaled particles as markers of small airway inflammation in subjects with asthma. Clin Physiol Funct Imaging. 2015; 37(5):489-497. DOI: 10.1111/cpf.12323. View

2.
Rodriguez-Capote K, Manzanares D, Haines T, Possmayer F . Reactive oxygen species inactivation of surfactant involves structural and functional alterations to surfactant proteins SP-B and SP-C. Biophys J. 2006; 90(8):2808-21. PMC: 1414557. DOI: 10.1529/biophysj.105.073106. View

3.
Broberg E, Pierre L, Fakhro M, Algotsson L, Malmsjo M, Hyllen S . Different particle flow patterns from the airways after recruitment manoeuvres using volume-controlled or pressure-controlled ventilation. Intensive Care Med Exp. 2019; 7(1):16. PMC: 6419649. DOI: 10.1186/s40635-019-0231-8. View

4.
Broberg E, Andreasson J, Fakhro M, Olin A, Wagner D, Hyllen S . Mechanically ventilated patients exhibit decreased particle flow in exhaled breath as compared to normal breathing patients. ERJ Open Res. 2020; 6(1). PMC: 7008139. DOI: 10.1183/23120541.00198-2019. View

5.
Sircar G, Saha B, Bhattacharya S, Saha S . Allergic asthma biomarkers using systems approaches. Front Genet. 2014; 4:308. PMC: 3884215. DOI: 10.3389/fgene.2013.00308. View